Infinity Pharmaceuticals

Infinity Pharmaceuticals Short-term Debt

The Short-Term Debt of Infinity Pharmaceuticals (INFIQ) as of Nov 20, 2026 is 593,000.00 USD. In the previous year, Short-Term Debt was 1.42 M USD — a change of -58.12% (lower).

Short-term Debt

593,000.00USD

YoY

-58.12%

Last updated:

Short-Term Debt of Infinity Pharmaceuticals is 2022 593,000.00 USD. Short-Term Debt of Infinity Pharmaceuticals was 2021 1.42 M USD. It decreases by -58.12% lower compared to the previous year.

The Infinity Pharmaceuticals Short-term Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Short-term Debt
Date
Short-term Debt
Jan 1, 2015
0.00 USD
Jan 1, 2016
0.00 USD
Jan 1, 2017
6.00 M USD
Jan 1, 2018
0.00 USD
Jan 1, 2019
381,000.00 USD
Jan 1, 2020
1.34 M USD
Jan 1, 2021
1.42 M USD
Jan 1, 2022
593,000.00 USD
The Infinity Pharmaceuticals Short-term Debt history
YEARShort-term DebtYoY
593,000.00USD-58.12%
1.42 MUSD+5.91%
1.34 MUSD+250.92%
381,000.00USD—
0.00USD-100.00%
6.00 MUSD—
0.00USD—
0.00USD—
0.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Infinity Pharmaceuticals Stock analysis

What does Infinity Pharmaceuticals do? Infinity Pharmaceuticals Inc. is a biopharmaceutical company based in Cambridge, Massachusetts. It was founded in 2001 and focuses on the discovery and development of novel therapies for cancer and other serious diseases. Infinity Pharmaceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Infinity Pharmaceuticals stock

Short-Term Debt of Infinity Pharmaceuticals is 593,000.00 USD in 2022.

Short-Term Debt of Infinity Pharmaceuticals changed from 1.42 M USD to 593,000.00 USD, representing a -58.12% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Short-Term Debt Infinity Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

Short-term debt represents borrowings due within one year. High short-term debt relative to cash can signal liquidity risk.

Short-Term Debt's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Short-Term Debt's Infinity Pharmaceuticals historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Infinity Pharmaceuticals

All Key Metrics — Infinity Pharmaceuticals